Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15790 articles
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer
Analyses provide valuable insights into unfavorable dose ratios for drug combinations.
»
08/02/24
Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis
Presence of SNPs linked to increased susceptibility to cold sores infection found to decrease risk of CRC.
»
08/10/24
Effect of the 2024 Noto Peninsula earthquake on outpatient chemotherapy among cancer survivors in Japan: a retrospective study
Most cancer survivors receiving chemotherapy able to maintain outpatient visits.
»
08/10/24
Location-Based Oncological Outcomes of Sentinel Node Dissection in Radical Prostatectomy.
Sentinel node location outside template associated with lower hazard of metastases.
»
08/08/24
Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response.
Low SHPRH mRNA expression associated with poor survival outcomes in LUAD patients.
»
09/20/23
Fragmentation of care in breast cancer: greater than the sum of its parts.
Treatment delay independently associated with increased risk of mortality.
»
05/20/24
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.
Zurletrectinib showed increased brain penetration.
»
02/15/24
Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay.
Potential clinical utility of ctDNA as tool to improve management of stage II and higher CRC.
»
08/01/24
Circulating tumor HPV DNA in the management of HPV+ oropharyngeal cancer and its correlation with MRI.
ctHPVDNA superior to p16 in identification of HPV-OPSCC at diagnosis.
»
06/20/24
Impact of intra-tumoral immunity on predicting response and survival after neoadjuvant cisplatin-based chemotherapy in patients with muscle invasive bladder cancer.
Lower NLR levels and increased CD3+ T cells and B cell infiltration associated with improved response.
»
06/29/24
< Prev
Next >